1 Riemann D, Espie CA, Altena E, et al. The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023. J Sleep Res. 2023. In press.
doi: https://doi.org/10.1111/jsr.14035
2 Riemann D, Baum E, Cohrs S, et al. S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen. Somnologie. 2017;21(1):2–44.
doi:10.1007/s11818-016-0097-x.
3 Maire M, Linder S, Dvořák C, et al. Prevalence and management of chronic insomnia in Swiss primary care: Cross-sectional data from the “Sentinella” practice-based research network. J Sleep Res. 2020;29(5):e13121.
4 Baglioni C, Battagliese G, Feige B, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135(1-3):10–19.
5 He Q, Zhang P, Li G, et al. The association between insomnia symptoms and risk of cardio-cerebral vascular events: A meta-analysis of prospective cohort studies. Eur J Prev Cardiol. 2017;24(10):1071–82.
6 Riemann D, Spiegelhalder K, Feige B, et al. The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev. 2010;14(1):19–31.
7 Riemann D, Nissen C, Palagini L, et al. The neurobiology, investigation, and treatment of chronic insomnia. Lancet Neurol. 2015;14(5):547–58.
8 Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am. 1987;10(4):541–53.
9 Fortier-Brochu E, Beaulieu-Bonneau S, Ivers H, et al. Insomnia and daytime cognitive performance: a meta-analysis. Sleep Med Rev. 2012;16(1):83–94.
10 Shekleton JA, Rogers NL, Rajaratnam SMW. Searching for the daytime impairments of primary insomnia. Sleep Med Rev. 2010;14(1):47–60.
11 Pollmächer T, Wetter TC, Bassetti CLA, et al. Handbuch Schlafmedizin; Pathophysiologie der Insomnien. 1st ed. Urban & Fischer/Elsevier; 2020. S 107–112.
12 Buysse DJ, Germain A, Hall M, et al. A Neurobiological Model of Insomnia. Drug Discov Today Dis Models. 2011;8(4):129–137.
13 Bouchequet P, Solelhac G, Andrillon T, et al. Quantifying Importance Of Electroencephalography Spectral Domain Features In Automatic Diagnosis Of Chronic Insomnia. Sleep. 2019;42:A130–A130.
14 Feige B, Al-Shajlawi A, Nissen C, et al. Does REM sleep contribute to subjective wake time in primary insomnia? A comparison of polysomnographic and subjective sleep in 100 patients. J Sleep Res. 2008;17(2):180–90.
15 Riemann D, Spiegelhalder K, Nissen C, et al. REM sleep instability--a new pathway for insomnia? Pharmacopsychiatry. 2012;45(5):167–76.
16 Ermann M, Peichl J, Pohl H, et al. [Spontaneous awakening and dreams of patients with psychophysiologic sleep disorders]. Psychother Psychosom Med Psychol. 1993;43(9-10):333–40.
17 Wassing R, Benjamins JS, Dekker K, et al. Slow dissolving of emotional distress contributes to hyperarousal. Proc Natl Acad Sci U S A. 2016;113(9):2538–43.
18 Feige B, Baglioni C, Spiegelhalder K, et al. The microstructure of sleep in primary insomnia: an overview and extension. Int J Psychophysiol. 2013;89(2):171–80.
19 Poe GR. Sleep Is for Forgetting. J Neurosci. 2017;37(3):464–73.
20 Walker MP, van der Helm E. Overnight therapy? The role of sleep in emotional brain processing. Psychol Bull. 2009;135(5):731–48.
21 van der Helm E, Yao J, Dutt S, et al. REM sleep depotentiates amygdala activity to previous emotional experiences. Curr Biol. 2011;21(23):2029–32.
22 Van Someren EJW. Brain mechanisms of insomnia: new perspectives on causes and consequences. Physiol Rev. 2021;101(3):995–1046.
23 Cartwright R, Luten A, Young M, et al. Role of REM sleep and dream affect in overnight mood regulation: a study of normal volunteers. Psychiatry Res. 1998;81(1):1–8.
24 Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.
25 Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.
26 Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):297–307.
27 Görtelmeyer R. Schlaffragebogen A und B. In: CIPS: Internationale Skalen für Psychiatrie. 5. Aufl. Weinheim: Beltz PVU; 2005. S. 357–370.
28 Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–545.
29 Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.
30 Frase L, Acker J, Cohrs S, et al. Empfehlungen zur Durchführung einer Polygraphie oder Polysomnographie im Bereich Psychiatrie und Psychotherapie: Positionspapier des DGPPN-Referats Schlafmedizin. Nervenarzt. 2020;91(9):843–53.
31 Ohayon MM, Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res. 2003;37(1):9–15.
32 Chakravorty S, Vandrey RG, He S, et al. Sleep Management Among Patients with Substance Use Disorders. Med Clin North Am. 2018;102(4):733–43.
33 Chaudhary NS, Grandner MA, Jackson NJ, et al. Caffeine consumption, insomnia, and sleep duration: Results from a nationally representative sample. Nutrition. 2016;32(11-12):1193–9.
34 Crönlein T, Geisler P, Langguth B, et al. Polysomnography reveals unexpectedly high rates of organic sleep disorders in patients with prediagnosed primary insomnia. Sleep Breath. 2012;16(4):1097–103.
35 Fietze I, Nötzel K, Blau A, et al. [Portable sleep monitoring in patients with disorders in falling asleep or maintaining sleep]. Nervenarzt. 2012;83(8):1021–7.
36 Garcia-Borreguero D, Kohnen R, Silber MH, et al. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group. Sleep Med. 2013;14(7):675–84.
37 Sharon D, Allen RP, Martinez-Martin P, et al. Validation of the self-administered version of the international Restless Legs Syndrome study group severity rating scale - The sIRLS. Sleep Med. 2019;54:94–100.
38 Lovato N, Lack L. The Role of Bright Light Therapy in Managing Insomnia. Sleep Medicine Clinics. 2013;8(3):351–9.
39 Dijk DJ, Duffy JF. Novel Approaches for Assessing Circadian Rhythmicity in Humans: A Review. J Biol Rhythms. 2020;35(5):421–38.
40 Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021;17(2):255–62.
41 Hertenstein E, Trinca E, Wunderlin M, et al. Cognitive behavioral therapy for insomnia in patients with mental disorders and comorbid insomnia: A systematic review and meta-analysis. Sleep Med Rev. 2022;62:101597.
42 Goulet J, Chaloult L, Ngô TL. Guide de pratique pour l’évaluation et le traitement cognitivo-comportemental de l’insomnie. 1st ed. Goulet J, editor. Montréal; 2018.
43 Hertenstein E, Spiegelhalder K, Johann A, Riemann D. Prävention und Psychotherapie der Insomnie; Konzepte, Methoden und Praxis der Freiburger Schlafschule. 1st ed. Stuttgart: Kohlhammer; 2015.
44 Morin CM, Espie CA. Insomnia – A Clinical Guide to Assessment and Treatment. 1st ed. New York: Springer; 2004.
45 Schneider CL, Hertenstein E, Fehér K, et al. Become your own SLEEPexpert: design, implementation, and preliminary evaluation of a pragmatic behavioral treatment program for insomnia in inpatient psychiatric care. SLEEP Advances. 2020;1(1):zpaa005.
46 Buscemi N, Vandermeer B, Friesen C, et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med. 2007;22(9):1335–50.
47 Winkler A, Auer C, Doering BK, et al. Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized controlled trials. CNS Drugs. 2014;28(9):799–816.
48 Everitt H, Baldwin DS, Stuart B, et al. Antidepressants for insomnia in adults. Cochrane Database Syst Rev. 2018;5(5):CD010753.
49 Yi XY, Ni SF, Ghadami MR, et al. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med. 2018;45:25–32.
50 Aslan S, Isik E, Cosar B. The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers. Sleep. 2002;25(6):677–9.
51 Winokur A, DeMartinis NA 3rd, McNally DP, et al. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia. J Clin Psychiatry. 2003;64(10):1224–9.
52 Karsten J, Hagenauw LA, Kamphuis J, et al. Low doses of mirtazapine or quetiapine for transient insomnia: A randomised, double-blind, cross-over, placebo-controlled trial. J Psychopharmacol. 2017;31(3):327–37.
53 Wilson S, Anderson K, Baldwin D, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. J Psychopharmacol. 2019;33(8):923–47.
54 Anderson SL, Vande Griend JP. Quetiapine for insomnia: A review of the literature. Am J Health Syst Pharm. 2014;71(5):394–402.
55 Bent S, Padula A, Moore D, et al. Valerian for sleep: a systematic review and meta-analysis. Am J Med. 2006;119(12):1005–12.
56 Tinguely G, Landolt HP, Cajochen C. Schlafgewohnheiten, Schlafqualität und Schlafmittelkonsum der Schweizer Bevölkerung – Ergebnisse aus einer neuen Umfrage bei einer repräsentativen Stichprobe. Therapeutische Umschau. 2014;71(11):637–46.
57 Vande Griend JP, Anderson S. Histamine-1 receptor antagonism for treatment of insomnia. J Am Pharm Assoc (2003). 2012;52(6):e210–219.
58 Choi K, Lee YJ, Park S, et al. Efficacy of melatonin for chronic insomnia: Systematic reviews and meta-analyses. Sleep Med Rev. 2022;66:101692.
59 Equihua AC, De La Herrán-Arita AK, Drucker-Colin R. Orexin receptor antagonists as therapeutic agents for insomnia. Front Pharmacol. 2013;4:163.
60 Mignot E, Mayleben D, Fietze I, et al. Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials. Lancet Neurol. 2022;21(2):125–39.
Mit der Kommentarfunktion bieten wir Raum für einen offenen und kritischen Fachaustausch. Dieser steht allen SHW Beta Abonnentinnen und Abonnenten offen. Wir publizieren Kommentare solange sie unseren Richtlinien entsprechen.